Outcome of Root Canal Treatments Obturated With Calcium Silicate Based Sealers
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Endodontically Treated Teeth
- Sponsor
- University of Bologna
- Enrollment
- 109
- Locations
- 1
- Primary Endpoint
- Healing rate
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The clinical use of a flowable premixed calcium-silicate bioceramic sealer used in association with warm carrier-based/single-cone technique will be compared with epoxy resin-based sealer with carrier-based technique.
Detailed Description
Healthy consecutive patients (n= 109) requiring 141 root canal treatments were enrolled in this study and divided in 3 groups (Group 1: Ceraseal + single cone cold technique n=47. Group 2: Ceraseal + Carrier-based technique n=47. Group 3 AH Plus + Carrier based technique n=47). Periapical X-rays were taken preoperatively, after root canal filling and after 6, 12 and 24 months. Two evaluators blindly assessed the Periapical Index (PAI) and sealer extrusion in the 3 groups (k =0.90). Healing rate and survival rate were also analysed. Chi square tests was used to analyse significant differences among the groups. Multilevel analysis was performed to analyse the factors associated to healing status and survival status.
Investigators
Fausto Zamparini
University of Bologna
University of Bologna
Eligibility Criteria
Inclusion Criteria
- •age 18-75 years
- •no use of antiresorptive or antiangiogenic drug
- •healthy status (ASA 1 or 2).
- •Needing one or more root canal treatment
Exclusion Criteria
- •Teeth with less than 2 walls of structural integrity
- •Wide apexes (\>40 diameter)
- •Any pathology that could compromise bone healing or the immune response,
- •pregnancy or breast feeding
- •heavy smoking (\>15 cigarettes/day), (Tverdal \& Bjartveit 2006)
- •exposure to radiation therapy focussed on the head and neck region and malignant disease directly involving the jaws.
- •Lacks of occlusal contacts
Outcomes
Primary Outcomes
Healing rate
Time Frame: 24 months
Periapical index minor than 3 at the endline
Secondary Outcomes
- Survival rate(24 months)